AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

Rhea-AI Summary

AccuStem Sciences, Inc. (OTCQB: ACUT) announced that its Chairman, Gabriele Cerrone, purchased an additional 9,447 shares, raising his total holdings to 3,801,226 shares. Cerrone expressed confidence in the company's direction, aligning his interests with fellow shareholders. AccuStem is focused on enhancing cancer patient outcomes, aiming to provide essential tools and answers in oncology while fostering healthcare innovation.

Positive

• Chairman Gabriele Cerrone increased his shareholding to 3,801,226, demonstrating confidence in the company's future.
• Cerrone's investment aligns his interests with those of other shareholders, suggesting commitment to driving shareholder value.

Negative

• None.

LONDON and PHOENIX, April 28, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 9,447 ACUT shares in the open market. This brings his total holding to 3,801,226 shares.

Gabriele Cerrone commented, "These open market share purchases of ACUT stock reflect my absolute confidence in what we are building at AccuStem. As the largest shareholder of AccuStem, my interests continue to be fully aligned with my fellow shareholders. I look forward to continuing to execute our plan to drive value for shareholders."

About AccuStem

AccuStem is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology- to empower patients and their care team with critical answers and tools and drive innovation in healthcare.

Media Contact:
Jeff Fensterer
Phone: 415-640-6010
Email: jeff@accustem.com

Investor Contact:
Wendy Blosser
Email: investors@accustem.com

FAQ

What recent share purchase did Gabriele Cerrone make for ACUT?

Gabriele Cerrone purchased an additional 9,447 shares of AccuStem Sciences (ACUT).

How many shares does Gabriele Cerrone hold in AccuStem Sciences?

After his recent purchase, Gabriele Cerrone holds a total of 3,801,226 shares of AccuStem Sciences (ACUT).

What is AccuStem Sciences focused on?

AccuStem Sciences is dedicated to improving outcomes for cancer patients and driving innovation in healthcare.